Published in N Engl J Med on June 10, 1999
Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci U S A (2001) 2.16
Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx (2004) 1.98
Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial. Lancet Neurol (2013) 1.93
Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev (2014) 1.76
Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke. Neurology (2009) 1.59
The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology (2008) 1.58
Acute ischaemic stroke. BMJ (2000) 1.52
Intravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patients. J Neurol Neurosurg Psychiatry (2005) 1.22
Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med (2010) 1.19
Ischemic stroke in the elderly: an overview of evidence. Nat Rev Neurol (2010) 1.15
Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window. Br J Pharmacol (2002) 1.06
Update on intravenous tissue plasminogen activator for acute stroke: from clinical trials to clinical practice. CMAJ (2001) 1.02
Intravenous tissue plasminogen activator and stroke in the elderly. Am J Emerg Med (2010) 0.98
Safety and efficacy of alteplase in the treatment of acute ischemic stroke. Vasc Health Risk Manag (2009) 0.98
Using global statistical tests in long-term Parkinson's disease clinical trials. Mov Disord (2009) 0.98
A user's guide to the NINDS rt-PA stroke trial database. PLoS Med (2008) 0.93
Safety of intravenous thrombolytic use in four emergency departments without acute stroke teams. Acad Emerg Med (2010) 0.91
Assessment of long-term outcomes for the STRokE DOC telemedicine trial. J Stroke Cerebrovasc Dis (2010) 0.90
Bayesian multiple imputation for missing multivariate longitudinal data from a Parkinson's disease clinical trial. Stat Methods Med Res (2012) 0.89
Enhancing community delivery of tissue plasminogen activator in stroke through community-academic collaborative clinical knowledge translation. Emerg Med Clin North Am (2009) 0.88
Intravenous rt-PA: a tenth anniversary reflection. Surg Neurol (2007) 0.86
NIHSS and acute complications after anterior and posterior circulation strokes. Ther Clin Risk Manag (2012) 0.85
Neuroprotective mechanisms of SMTP-7 in cerebral infarction model in mice. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.85
The potential roles of 18F-FDG-PET in management of acute stroke patients. Biomed Res Int (2013) 0.84
Identification of stroke mimics in the emergency department setting. J Brain Dis (2009) 0.84
Disruption of striatal-enriched protein tyrosine phosphatase (STEP) function in neuropsychiatric disorders. Neurosci Res (2014) 0.83
Rapid Short MRI Sequence Useful in Eliminating Stroke Mimics Among Acute Stroke Patients Considered for Intravenous Thrombolysis. J Neurol Disord (2013) 0.83
Thrombolysis for cerebral ischemia. Front Neurol (2010) 0.83
Cognitive and functional outcome after intravenous recombinant tissue plasminogen activator treatment in patients with a first symptomatic brain infarct. J Neurol (2005) 0.82
Intravenous thrombolytics for ischemic stroke. Neurotherapeutics (2011) 0.81
Kids Identifying and Defeating Stroke (KIDS): development and implementation of a multiethnic health education intervention to increase stroke awareness among middle school students and their parents. Health Promot Pract (2008) 0.81
Tissue plasminogen activator for acute ischemic stroke. N Engl J Med (1999) 0.81
Collaterals: Implications in cerebral ischemic diseases and therapeutic interventions. Brain Res (2015) 0.81
Antiplatelet therapy, but not intravenous thrombolytic therapy, is associated with postoperative bleeding complications after decompressive craniectomy for stroke. J Neurol (2013) 0.80
Subclinical thyroid dysfunction and functional capacity among elderly. Thyroid (2013) 0.80
Hemostasis and alterations of the central nervous system. Semin Thromb Hemost (2013) 0.79
Acute ischemic stroke treatment, part 1: patient selection "the 50% barrier and the capillary index score". Front Neurol (2015) 0.79
Aspirin treatment failure and the risk of recurrent stroke and death among patients with ischemic stroke. J Stroke Cerebrovasc Dis (2011) 0.78
Experimental validation of a finite-difference model for the prediction of transcranial ultrasound fields based on CT images. Phys Med Biol (2012) 0.78
Regression analysis of ordinal stroke clinical trial outcomes: an application to the NINDS t-PA trial. Int J Stroke (2013) 0.78
Quality of life of elderly ischaemic stroke patients one year after thrombolytic therapy. A comparison between patients with and without thrombolytic therapy. BMC Neurol (2012) 0.78
Development and initial testing of the stroke rapid-treatment readiness tool. J Neurosci Nurs (2014) 0.78
Type 2 diabetes is cardiovascular disease. J R Soc Med (2003) 0.78
Vascular Risk Factors in Patients with Different Subtypes of Ischemic Stroke May Affect Their Outcome after Intravenous tPA. PLoS One (2015) 0.78
Pharmacological and non-pharmacological recanalization strategies in acute ischemic stroke. Front Neurol (2011) 0.77
Thrombolysis risk prediction: applying the SITS-SICH and SEDAN scores in South African patients. Cardiovasc J Afr (2015) 0.77
Stroke management. BMJ Clin Evid (2011) 0.77
Plasminogen activators and ischemic stroke: conditions for acute delivery. Semin Thromb Hemost (2013) 0.77
Impact of disability on different domains of health-related quality of life in the noninstitutionalized general population. Clinicoecon Outcomes Res (2010) 0.77
Predictors of discharge to home after thrombolytic treatment in right hemisphere infarct patients. J Cent Nerv Syst Dis (2010) 0.77
Effectiveness of home rehabilitation for ischemic stroke. Neurol Int (2009) 0.77
Why don't more patients receive intravenous rt-PA for acute stroke? Expert Rev Neurother (2015) 0.76
Endovascular therapy in hyperacute ischaemic stroke: history and current status. Interv Neuroradiol (2013) 0.76
Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats. Int J Nanomedicine (2016) 0.76
Does body weight influence the response to intravenous tissue plasminogen activator in stroke patients? Cerebrovasc Dis (2008) 0.76
Sex, diastolic blood pressure, and outcome after thrombolysis for ischemic stroke. Stroke Res Treat (2014) 0.75
Understanding commonly encountered limitations in clinical research: an emergency medicine resident's perspective. Ann Emerg Med (2011) 0.75
Effect of alteplase within 6 hours of acute ischemic stroke on all-cause mortality (third International Stroke Trial). Stroke (2014) 0.75
Thrombolysis in acute ischaemic stroke. Postgrad Med J (2001) 0.75
Influence of Aerobic Training and Combinations of Interventions on Cognition and Neuroplasticity after Stroke. Front Aging Neurosci (2016) 0.75
Modeling stroke management: a qualitative review of cost-effectiveness analyses. Eur J Health Econ (2010) 0.75
Measurements of acute cerebral infarction: a clinical examination scale. Stroke (1989) 14.54
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
Spontaneous intracerebral hemorrhage. N Engl J Med (2001) 8.60
Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA (2000) 7.25
The ABCs of measuring intracerebral hemorrhage volumes. Stroke (1996) 6.78
Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke (2001) 6.61
Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci U S A (1997) 5.76
A method for efficient isotopic labeling of recombinant proteins. J Biomol NMR (2001) 4.96
The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke (1998) 4.93
Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke (2001) 4.64
Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology (2002) 4.45
Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke (1994) 4.45
Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med (2000) 4.33
Public perception of stroke warning signs and knowledge of potential risk factors. JAMA (1998) 4.21
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology (2000) 4.13
Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology (2007) 3.73
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology (1998) 3.62
The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med (1992) 3.56
Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med (1999) 3.54
Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology (2009) 3.45
The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology (2007) 3.24
The effect of trauma and confinement on functional health and mental health status of Cambodians living in Thailand-Cambodia border camps. JAMA (1993) 3.13
Projected costs of ischemic stroke in the United States. Neurology (2006) 2.93
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke (1997) 2.87
Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke (1999) 2.85
Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci (2001) 2.84
Long-term mortality after intracerebral hemorrhage. Neurology (2006) 2.71
A comparison of pregnancy history recall and medical records. Implications for retrospective studies. Am J Epidemiol (1985) 2.65
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
CaMKIIalpha 3' untranslated region-directed mRNA translocation in living neurons: visualization by GFP linkage. J Neurosci (2000) 2.64
A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry (1995) 2.57
Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport (2000) 2.49
Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum Gene Ther (1998) 2.29
Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke (1999) 2.28
Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke (1998) 2.25
Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA (2001) 2.24
Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke (1998) 2.23
Circadian variation in onset of acute ischemic stroke. Arch Neurol (1990) 2.22
Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg (1993) 2.22
Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators. Stroke (1999) 2.21
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke (1999) 2.17
A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity. Stroke (2001) 2.16
Early treatment for acute ischemic stroke. Ann Intern Med (1989) 2.15
The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology (2007) 2.13
Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomarkers Prev (1997) 2.13
A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein. J Virol (1998) 2.12
The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology (1995) 2.10
Health care use among undocumented Latino immigrants. Health Aff (Millwood) (2000) 2.06
Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase. Mol Cell Biol (2001) 2.06
Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol (1996) 2.05
Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment. Neurology (2003) 2.04
Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin. Lancet (1995) 2.03
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology (2002) 2.02
Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology (2001) 2.02
Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer. Cancer (1985) 2.01
Thrombolytic therapy for cerebral infarction. Acad Emerg Med (1996) 1.99
Ataxic hemiparesis: critical appraisal of a lacunar syndrome. Stroke (1998) 1.98
Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology (2007) 1.97
Do-not-resuscitate orders and predictive models after intracerebral hemorrhage. Neurology (2010) 1.97
Diagnosis and management of neurological sarcoidosis. Arch Intern Med (1997) 1.93
Whatever happened to the health insurance crisis in the United States? Voices from a national survey. JAMA (1996) 1.92
Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine. Stroke (1995) 1.91
Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells. Neurosurgery (2001) 1.87
Patients' awareness of stroke signs, symptoms, and risk factors. Stroke (1997) 1.85
Comparison of laboratory test frequency and test results between African-Americans and Caucasians with diabetes: opportunity for improvement. Findings from a large urban health maintenance organization. Diabetes Care (1997) 1.83